ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,008.47
      1.31%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      10/25/200610:33AMPR Newswire (US)/C O R R E C T I O N from Source -- AEterna Zentaris Inc./NASDAQ:AEZS
      10/25/20068:30AMPR Newswire (US)AEterna Zentaris Announces Details of Distribution of its Remaining Shares of Atrium Biotechnologies Inc.NASDAQ:AEZS
      10/24/20068:00AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming C.E. Unterberg, Towbin Life Sciences Conference and SIG's Emerging Trend Conference in NNASDAQ:AEZS
      10/24/20068:00AMPR Newswire (US)Aeterna Zentaris to Present at Upcoming C.E. Unterberg, Towbin Life Sciences Conference and SIG's Emerging Trend Conference in NNASDAQ:AEZS
      10/19/20068:30AMPR Newswire (US)AEterna Zentaris to Present First In Vivo Data on Ghrelin Antagonists' Capacity of Selectively Inhibiting Food IntakeNASDAQ:AEZS
      10/18/20069:23AMPR Newswire (US)AEterna Zentaris Announces Closing of Secondary Offering of Shares of Atrium Biotechnologies Inc.NASDAQ:AEZS
      10/03/20068:35AMPR Newswire (US)AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix in Benign Prostatic HyperplasiaNASDAQ:AEZS
      10/03/20068:35AMPR Newswire (US)Spectrum Pharmaceuticals Announces Positive Phase 2 Data with Ozarelix in Patients with Benign Prostatic HypertrophyNASDAQ:AEZS
      09/27/20068:00AMPR Newswire (US)AEterna Zentaris to Present at Upcoming Bio Investor Forum in San Francisco and Bio Contact in Quebec CityNASDAQ:AEZS
      09/21/20068:30AMPR Newswire (US)AEterna Zentaris Launches Cetrotide(R) (cetrorelix) in Japan for In Vitro FertilizationNASDAQ:AEZS
      08/11/200610:09AMPR Newswire (US)/C O R R E C T I O N from Source - AEterna Zentaris Inc./NASDAQ:AEZS
      08/11/20069:22AMPR Newswire (US)AEterna Zentaris Reports 2006 Second Quarter ResultsNASDAQ:AEZS
      08/03/20068:30AMPR Newswire (US)AEterna Zentaris will disclose 2006 second quarter financial and operating results on August 11NASDAQ:AEZS
      08/03/20068:00AMPR Newswire (US)AEterna Zentaris Enters a License and Collaboration Agreement for Ozarelix with Nippon Kayaku for the Japanese MarketNASDAQ:AEZS
      08/02/20068:30AMPR Newswire (US)Spectrum Pharmaceuticals Announces Phase 2 Data for Ozarelix in Hormone-Dependent Prostate CancerNASDAQ:AEZSAeterna Zentaris Inc
      08/02/20068:00AMPR Newswire (US)AEterna Zentaris Announces Positive Phase 2 Results for Ozarelix (D-63153) in Hormone-Dependent Inoperable Prostate CancerNASDAQ:AEZS
      06/27/20068:00AMPR Newswire (US)AEterna Zentaris Presented Positive In Vivo Data on ZEN-019, an Oral, LHRH Antagonist Peptidomimetic, at ENDO 2006 in BostonNASDAQ:AEZS
      06/21/20068:00AMPR Newswire (US)AEterna Zentaris Receives Green Light from FDA to Move Forward into Phase 3 Program with Cetrorelix in BPHNASDAQ:AEZS
      06/19/20068:00AMPR Newswire (US)Echelon Biosciences granted US Patent for PI3K reinforcing its leadership in the commercialization of cancer assaysNASDAQ:AEZSAeterna Zentaris Inc
      06/06/20068:01AMPR Newswire (US)AEterna Zentaris to Present at Upcoming Pacific Growth Equities Conference in San Francisco and Orion Securities Conference atNASDAQ:AEZS
      06/05/20068:15AMPR Newswire (US)AEterna Zentaris Announces Positive Data of Perifosine (KRX-0401) in patients with advanced renal cell carcinoma at ASCO MeetinNASDAQ:AEZS
      06/05/20068:00AMPR Newswire (US)AEterna Zentaris Reports Positive Results from ongoing Phase 1 Trial with AN-152 in Patients with Gynaecological and Breast CanNASDAQ:AEZS
      05/25/200612:49PMPR Newswire (US)AEterna Zentaris to Present at Upcoming Canaccord Adams Life Sciences Mini-Conference in MontrealNASDAQ:AEZS
      05/24/20068:00AMPR Newswire (US)TYRIA, IBM and AEZS Update the Investment Community in All-New Interviews With www.wallst.netNASDAQ:AEZSAeterna Zentaris Inc
      05/16/20068:00AMPR Newswire (US)AEterna Zentaris to Present at Upcoming Bio Equity Europe 2006 in Frankfurt, GermanyNASDAQ:AEZS
      05/08/20062:21PMPR Newswire (US)AEterna Zentaris to Present at Upcoming Rodman & Renshaw Conference in MonacoNASDAQ:AEZS
      05/03/200611:46AMPR Newswire (US)AEterna Zentaris Announces Research Project with the University of Montreal on its Ghrelin Antagonist Compounds for Obesity atNASDAQ:AEZS
      05/03/20068:01AMPR Newswire (US)AEterna Zentaris Reports 2006 First Quarter Financial and Operating ResultsNASDAQ:AEZS
      04/25/20068:00AMPR Newswire (US)AEterna Zentaris Will Disclose 2006 First Quarter Financial and Operating Results and Hold Annual General Meeting at the CentreNASDAQ:AEZS
      04/20/200611:58AMPR Newswire (US)AEterna Zentaris Gains Market Approval for Cetrotide(R) (cetrorelix) in Japan for In Vitro FertilizationNASDAQ:AEZS
       Showing the most relevant articles for your search:NASDAQ:AEZS